133 related articles for article (PubMed ID: 35687134)
21. Temporal lobe injury patterns following intensity modulated radiotherapy in a large cohort of nasopharyngeal carcinoma patients.
Lu L; Sheng Y; Zhang G; Li Y; OuYang PY; Ge Y; Xie T; Chang H; Deng X; Wu JQ
Oral Oncol; 2018 Oct; 85():8-14. PubMed ID: 30220323
[TBL] [Abstract][Full Text] [Related]
22. Altered properties of brain white matter structural networks in patients with nasopharyngeal carcinoma after radiotherapy.
Chen Q; Lv X; Zhang S; Lin J; Song J; Cao B; Weng Y; Li L; Huang R
Brain Imaging Behav; 2020 Dec; 14(6):2745-2761. PubMed ID: 31900892
[TBL] [Abstract][Full Text] [Related]
23. Changes in brain gray matter volume in nasopharyngeal carcinoma patients after radiotherapy in long-term follow-up.
Zhu W; Chen F; Yin D; Chen K; Wang S
Braz J Otorhinolaryngol; 2023; 89(3):477-484. PubMed ID: 36805347
[TBL] [Abstract][Full Text] [Related]
24. A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Cai J; Cheng J; Li H; Lin WJ; Li Y; Zhuo X; Huang X; Simone CB; Aronow WS; Chow ELW; Tang Y
Radiother Oncol; 2019 Mar; 132():34-41. PubMed ID: 30825967
[TBL] [Abstract][Full Text] [Related]
25. A deep learning-based method for the prediction of temporal lobe injury in patients with nasopharyngeal carcinoma.
Ren W; Liang B; Sun C; Wu R; Men K; Chen H; Feng X; Hou L; Han F; Yi J; Dai J
Phys Med; 2024 May; 121():103362. PubMed ID: 38653120
[TBL] [Abstract][Full Text] [Related]
26. Diffusion Kurtosis as an in vivo Imaging Marker of Early Radiation-Induced Changes in Radiation-Induced Temporal Lobe Necrosis in Nasopharyngeal Carcinoma Patients.
Liyan L; Si W; Qian W; Yuhui S; Xiaoer W; Yuehua L; Wenbin L
Clin Neuroradiol; 2018 Sep; 28(3):413-420. PubMed ID: 28447147
[TBL] [Abstract][Full Text] [Related]
27. Dosimetric analysis of radiation-induced brainstem necrosis for nasopharyngeal carcinoma treated with IMRT.
Fan X; Huang Y; Xu P; Min Y; Li J; Feng M; Xu G; Lang J
BMC Cancer; 2022 Feb; 22(1):178. PubMed ID: 35177030
[TBL] [Abstract][Full Text] [Related]
28. MRI-based radiomics nomogram for predicting temporal lobe injury after radiotherapy in nasopharyngeal carcinoma.
Hou J; Li H; Zeng B; Pang P; Ai Z; Li F; Lu Q; Yu X
Eur Radiol; 2022 Feb; 32(2):1106-1114. PubMed ID: 34467454
[TBL] [Abstract][Full Text] [Related]
29. Long-term outcomes of nasopharyngeal carcinoma patients with T1-2 stage in intensity-modulated radiotherapy era.
Niu X; Xue F; Liu P; Hu C; He X
Int J Med Sci; 2022; 19(2):267-273. PubMed ID: 35165512
[No Abstract] [Full Text] [Related]
30. Development of a normal tissue complication probability (NTCP) model for radiation-induced hypothyroidism in nasopharyngeal carcinoma patients.
Luo R; Wu VWC; He B; Gao X; Xu Z; Wang D; Yang Z; Li M; Lin Z
BMC Cancer; 2018 May; 18(1):575. PubMed ID: 29776390
[TBL] [Abstract][Full Text] [Related]
31. Effect of dosimetric factors on occurrence and volume of temporal lobe necrosis following intensity modulated radiation therapy for nasopharyngeal carcinoma: a case-control study.
Zhou X; Ou X; Xu T; Wang X; Shen C; Ding J; Hu C
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):261-9. PubMed ID: 25066214
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
[TBL] [Abstract][Full Text] [Related]
33. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
Li Y; Xu T; Qian W; Lu X; Hu C
Oral Oncol; 2018 Sep; 84():1-6. PubMed ID: 30115466
[TBL] [Abstract][Full Text] [Related]
34. 1H-MR spectroscopy and diffusion tensor imaging of normal-appearing temporal white matter in patients with nasopharyngeal carcinoma after irradiation: initial experience.
Xiong WF; Qiu SJ; Wang HZ; Lv XF
J Magn Reson Imaging; 2013 Jan; 37(1):101-8. PubMed ID: 22972703
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy.
Wang J; Miao Y; Ou X; Wang X; He X; Shen C; Ying H; Hu W; Hu C
Radiat Oncol; 2019 Mar; 14(1):42. PubMed ID: 30866964
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
[TBL] [Abstract][Full Text] [Related]
37. Radiation-induced changes in normal-appearing gray matter in patients with nasopharyngeal carcinoma: a magnetic resonance imaging voxel-based morphometry study.
Lv XF; Zheng XL; Zhang WD; Liu LZ; Zhang YM; Chen MY; Li L
Neuroradiology; 2014 May; 56(5):423-30. PubMed ID: 24609527
[TBL] [Abstract][Full Text] [Related]
38. Irradiation-induced nasopharyngeal necrosis (INN) in newly diagnosed nasopharyngeal carcinoma treated by intensity-modulated radiation therapy: clinical characteristics and the influence of treatment strategies.
Xu Y; Liu Y; Wang Z; Wang J; Zhang J; Chen X; Wu R; Liu Q; Qu Y; Wang K; Huang X; Luo J; Gao L; Xu G; Zhang Y; Yi J
Radiat Oncol; 2022 Jan; 17(1):13. PubMed ID: 35062991
[TBL] [Abstract][Full Text] [Related]
39. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
[TBL] [Abstract][Full Text] [Related]
40. Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.
Su SF; Huang SM; Han F; Huang Y; Chen CY; Xiao WW; Sun XM; Lu TX
Radiat Oncol; 2013 Jan; 8():17. PubMed ID: 23336282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]